Page last updated: 2024-10-29

irsogladine and Pancreatic Neoplasms

irsogladine has been researched along with Pancreatic Neoplasms in 1 studies

irsogladine: RN given refers to parent cpd; MN 1695 refers to maleate salt

Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kawasaki, Y1
Tsuchida, A1
Sasaki, T1
Yamasaki, S1
Kuwada, Y1
Murakami, M1
Chayama, K1

Other Studies

1 other study available for irsogladine and Pancreatic Neoplasms

ArticleYear
Irsogladine malate up-regulates gap junctional intercellular communication between pancreatic cancer cells via PKA pathway.
    Pancreas, 2002, Volume: 25, Issue:4

    Topics: Animals; Antineoplastic Agents; Biological Transport; Cell Communication; Cell Line; Connexin 43; Cy

2002